Generic placeholder image

Infectious Disorders - Drug Targets

Editor-in-Chief

ISSN (Print): 1871-5265
ISSN (Online): 2212-3989

Letter to the Editor

Can an International Student Group at TUMS in Iran Be a Role Model in the Development of Applied Scientific Evidence in the Era of COVID-19 through Mentorship?

Author(s): SeyedAhmad SeyedAlinaghi and Esmaeil Mehraeen*

Volume 24, Issue 7, 2024

Published on: 07 February, 2024

Article ID: e070224226751 Pages: 3

DOI: 10.2174/0118715265277394240124070914

Price: $65

[1]
Mehraeen E, Noori T, Nazeri Z, et al. Identifying features of a mobile-based application for self-care of people living with T2DM. Diabetes Res Clin Pract 2021; 171: 108544.
[2]
Mehraeen E, Behnezhad F, Salehi MA, Noori T, Harandi H, SeyedAlinaghi S. Olfactory and gustatory dysfunctions due to the coronavirus disease (COVID-19): A000000000000000000 review of current evidence. Eur Arch Otorhinolaryngol 2021; 278(2): 307-12.
[http://dx.doi.org/10.1007/s00405-020-06120-6] [PMID: 32556781]
[3]
Mehraeen E, Salehi MA, Behnezhad F, Moghaddam HR. Transmission modes of COVID-19: A systematic review. Infect Disord Drug Targets 2021; 21(6): 27-34.
[4]
Mehraeen E, Hayati B, Saeidi S, Heydari M, Seyedalinaghi S. Self-care instructions for people not requiring hospitalization for coronavirus disease 2019 (COVID-19). Arch Clin Infect Dis 2020; 15: e102978.
[5]
Mehraeen E, Seyed Alinaghi SA, Nowroozi A, et al. A systematic review of ECG findings in patients with COVID-19. Indian Heart J 2020; 72(6): 500-7.
[http://dx.doi.org/10.1016/j.ihj.2020.11.007] [PMID: 33357637]
[6]
Mehraeen E, SeyedAlinaghi S, Karimi A. Can children of the Sputnik V vaccine recipients become symptomatic? Hum Vaccin Immunother 2021; 17(10): 3500-1.
[http://dx.doi.org/10.1080/21645515.2021.1933689] [PMID: 34241575]
[7]
SeyedAlinaghi S, Afsahi AM, MohsseniPour M, et al. Late complications of COVID-19; A systematic review of current evidence. Arch Acad Emerg Med 2021; 9(1): e14.
[PMID: 33681819]
[8]
Mehraeen E, Safdari R, SeyedAlinaghi S, Mohammadzadeh N. Exploring and prioritization of mobile-based self-management strategies for HIV care. Infect Disord Drug Targets 2019; 19(3): 288-96.
[http://dx.doi.org/10.2174/1871526518666181022113900] [PMID: 30345930]
[9]
Mehraeen E, Safdari R, SeyedAlinaghi SA, Noori T, Kahouei M, Soltani-Kermanshahi M. A mobile-based self-management application- usability evaluation from the perspective of HIV-positive people. Health Policy Technol 2020; 9(3): 294-301.
[http://dx.doi.org/10.1016/j.hlpt.2020.06.004]
[10]
Shahmohamadi E, SeyedAlinaghi SA, Karimi A, Behnezhad F, Mehraeen E, Dadras O. HIV/HTLV-1 co-infection: A systematic review of current evidence. HIV AIDS Rev 2021; 20(3): 158-65.
[http://dx.doi.org/10.5114/hivar.2021.108835]
[11]
Mehrtak M, SeyedAlinaghi S, MohsseniPour M, et al. Security challenges and solutions using healthcare cloud computing. J Med Life 2021; 14(4): 448-61.
[http://dx.doi.org/10.25122/jml-2021-0100] [PMID: 34621367]
[12]
Safdari R. Developing Aysoo: a mobile-based self-management application for people living with HIV. HIV & AIDS Review International Journal of HIV-Related Problems 2020; 21(1): 24-30.
[13]
Mehraeen E, Oliaei S, SeyedAlinaghi S, et al. COVID-19 in Pediatrics: A Systematic Review of Current Knowledge and Practice. Infect Disord Drug Targets 2022; 22(5): e290921196908.
[http://dx.doi.org/10.2174/1871526521666210929121705] [PMID: 34587889]
[14]
Mehraeen E, Mehrtak M, SeyedAlinaghi S, et al. Technology in the Era of COVID-19: A Systematic Review of Current Evidence. Infect Disord Drug Targets 2022; 22(4): e240322202551.
[http://dx.doi.org/10.2174/1871526522666220324090245] [PMID: 35331123]
[15]
Alinaghi SA, Janfaza N, Mirzapour P, et al. The Upper-gastrointestinal Endoscopic Findings of People Living with HIV: A Systematic Review. Curr HIV Res 2024 Jan 25. Epub ahead of print
[http://dx.doi.org/10.2174/011570162X271270231215101009] [PMID: 38279732]
[16]
Dadras O, Afsahi AM, Pashaei Z, et al. The relationship between COVID‐19 viral load and disease severity: A systematic review. Immun Inflamm Dis 2022; 10(3): e580.
[http://dx.doi.org/10.1002/iid3.580] [PMID: 34904379]
[17]
SeyedAlinaghi S, Mirzapour P, Dadras O, et al. Characterization of SARS-CoV-2 different variants and related morbidity and mortality: A systematic review. Eur J Med Res 2021; 26(1): 51.
[http://dx.doi.org/10.1186/s40001-021-00524-8] [PMID: 34103090]
[18]
SeyedAlinaghi S, Shahidi R, Mojdeganlou H, et al. The effect of macronutrient and micronutrient supplements on COVID-19: an umbrella review. J Health Popul Nutr 2024 Jan 29; 43(1): 16.
[http://dx.doi.org/10.1186/s41043-024-00504-8] [PMID: 38287379] [PMCID: PMC10826055]
[19]
Mehraeen E, Karimi A, Barzegary A, et al. Predictors of mortality in patients with COVID-19–a systematic review. Eur J Integr Med 2020; 40: 101226.
[http://dx.doi.org/10.1016/j.eujim.2020.101226] [PMID: 33101547]
[20]
Mehraeen E, Abbaspour F, Banach M, SeyedAlinaghi S, Zarebidoki A, Tamehri Zadeh SS. The prognostic significance of insulin resistance in COVID-19: a review. Journal of Diabetes & Metabolic Disorders 2024 Jan 20; 1-8.
[21]
SeyedAlinaghi S, Ghayomzadeh M, Mirzapour P, et al. A systematic review of sarcopenia prevalence and associated factors in people living with human immunodeficiency virus. J Cachexia Sarcopenia Muscle 2023 Jun; 14(3): 1168-82. Epub 2023 Mar 16.
[http://dx.doi.org/10.1002/jcsm.13212] [PMID: 36929581] [PMCID: PMC10235901]
[22]
SeyedAlinaghi S, Afsahi AM, Shahidi R, et al. Social stigma during COVID-19: A systematic review. SAGE Open Med 2023 Nov 10; 11: 20503121231208273.
[http://dx.doi.org/10.1177/20503121231208273] [PMID: 38020797] [PMCID: PMC10640804]
[23]
SeyedAlinaghi S, Afsahi AM, Moradi A, et al. Current ART, determinants for virologic failure and implications for HIV drug resistance: an umbrella review. AIDS Res Ther 2023 Oct 27; 20(1): 74.
[http://dx.doi.org/10.1186/s12981-023-00572-6] [PMID: 37884997] [PMCID: PMC10604802]
[24]
SeyedAlinaghi S, Karimi A, Afsahi AM, et al. The Effectiveness of Face Masks in Preventing COVID-19 Transmission: A Systematic Review. Infect Disord Drug Targets 2023 Jun 1. Epub ahead of print
[http://dx.doi.org/10.2174/1871526523666230601090905] [PMID: 37259934]
[25]
Alinaghi SAS, Afzalian A, Dashti M, et al. Estimating Hidden Population Size of COVID-19 Using Respondent- Driven Sampling Method - A Systematic Review. Infect Disord Drug Targets 2024 Jan 31. Epub ahead of print
[http://dx.doi.org/10.2174/0118715265277789240110043215] [PMID: 38299412]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy